CD14-negative isolation enhances chondrogenesis in synovial fibroblasts.
Journal: 2010/January - Tissue Engineering - Part A.
ISSN: 1937-335X
Abstract:
Synovial membrane has been shown to contain mesenchymal stem cells. We hypothesized that an enriched population of synovial fibroblasts would undergo chondrogenic differentiation and secrete cartilage extracellular matrix to a greater extent than would a mixed synovial cell population (MSCP). The optimum doses of transforming growth factor beta 1 (TGF-beta1) and insulin-like growth factor 1 (IGF-1) for chondrogenesis were investigated. CD14-negative isolation was used to obtain a porcine cell population enriched in type-B synovial fibroblasts (SFB) from an MSCP. The positive cell surface markers in SFB were CD90, CD44, and cadherin-11. SFB and MSCP were cultured in the presence of 20 ng/mL TGF-beta1 for 7 days, and SFB were demonstrated to have higher chondrogenic potential. Further dose-response studies were carried out using the SFB cells and several doses of TGF-beta1 (2, 10, 20, and 40 ng/mL) and/or IGF-1 (1, 10, 100, and 500 ng/mL) for 14 days. TGF-beta1 supplementation was essential for chondrogenesis and prevention of cell death, whereas IGF-1 did not have a significant effect on the SFB cell number or glycosaminoglycan production. This study demonstrates that the CD14-negative isolation yields an enhanced cell population SFB that is more potent than MSCP as a cell source for cartilage tissue engineering.
Relations:
Content
Citations
(12)
References
(37)
Chemicals
(2)
Genes
(1)
Organisms
(2)
Processes
(1)
Anatomy
(3)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Tissue Eng Part A 15(11): 3261-3270

CD14-Negative Isolation Enhances Chondrogenesis in Synovial Fibroblasts

Department of Orthopaedics, Alpert Medical School of Brown University and Center for Restorative and Regenerative Medicine, Providence VA Medical Center and Brown University, Providence, Rhode Island.
Department of Orthopaedics, Alpert Medical School of Brown University, Providence, Rhode Island.
Department of Orthopaedics, West Virginia University, Morgantown, West Virginia.
Corresponding author.
Address correspondence to: Deborah McK. Ciombor, Ph.D., Department of Orthopaedics, Alpert Medical School of Brown University and Center for Restorative and Regenerative Medicine, Providence VA Medical Center and Brown University, Coro West Suite 402 C, 1 Hoppin St., Providence, RI 02903. E-mail:ude.nworb@robmoic_harobed
Address correspondence to: Deborah McK. Ciombor, Ph.D., Department of Orthopaedics, Alpert Medical School of Brown University and Center for Restorative and Regenerative Medicine, Providence VA Medical Center and Brown University, Coro West Suite 402 C, 1 Hoppin St., Providence, RI 02903. E-mail:ude.nworb@robmoic_harobed
Received 2008 May 8; Accepted 2009 Apr 21.

Abstract

Synovial membrane has been shown to contain mesenchymal stem cells. We hypothesized that an enriched population of synovial fibroblasts would undergo chondrogenic differentiation and secrete cartilage extracellular matrix to a greater extent than would a mixed synovial cell population (MSCP). The optimum doses of transforming growth factor beta 1 (TGF-β1) and insulin-like growth factor 1 (IGF-1) for chondrogenesis were investigated. CD14-negative isolation was used to obtain a porcine cell population enriched in type-B synovial fibroblasts (SFB) from an MSCP. The positive cell surface markers in SFB were CD90, CD44, and cadherin-11. SFB and MSCP were cultured in the presence of 20 ng/mL TGF-β1 for 7 days, and SFB were demonstrated to have higher chondrogenic potential. Further dose–response studies were carried out using the SFB cells and several doses of TGF-β1 (2, 10, 20, and 40 ng/mL) and/or IGF-1 (1, 10, 100, and 500 ng/mL) for 14 days. TGF-β1 supplementation was essential for chondrogenesis and prevention of cell death, whereas IGF-1 did not have a significant effect on the SFB cell number or glycosaminoglycan production. This study demonstrates that the CD14-negative isolation yields an enhanced cell population SFB that is more potent than MSCP as a cell source for cartilage tissue engineering.

Abstract

References

  • 1. Freed L.E. Marquis J.C. Nohria A. Emmanual J. Mikos A.G. Langer R. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res. 1993;27:11.[PubMed]
  • 2. Vacanti C.A. Langer R. Schloo B. Vacanti J.P. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg. 1991;88:753.[PubMed]
  • 3. Nehrer S. Breinan H.A. Ramappa A. Hsu H.P. Minas T. Shortkroff S. Sledge C.B. Yannas I.V. Spector M. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials. 1998;19:2313.[PubMed]
  • 4. Dell'Accio F. De Bari C. Luyten F.P. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum. 2001;44:1608.[PubMed]
  • 5. Tanaka H. Murphy C.L. Murphy C. Kimura M. Kawai S. Polak J.M. Chondrogenic differentiation of murine embryonic stem cells: effects of culture conditions and dexamethasone. J Cell Biochem. 2004;93:454.[PubMed]
  • 6. Erickson G.R. Gimble J.M. Franklin D.M. Rice H.E. Awad H. Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;290:763.[PubMed]
  • 7. Tuli R. Nandi S. Li W.J. Tuli S. Huang X. Manner P.A. Laquerriere P. Noth U. Hall D.J. Tuan R.S. Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng. 2004;10:1169.[PubMed]
  • 8. Guilak F. Awad H.A. Fermor B. Leddy H.A. Gimble J.M. Adipose-derived adult stem cells for cartilage tissue engineering. Biorheology. 2004;41:389.[PubMed]
  • 9. De Bari C. Dell'Accio F. Luyten F.P. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 2001;44:85.[PubMed]
  • 10. De Bari C. Dell'Accio F. Tylzanowski P. Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928.[PubMed]
  • 11. Iwata H. Ono S. Sato K. Sato T. Kawamura M. Bone morphogenetic protein-induced muscle- and synovium-derived cartilage differentiation in vitro. Clin Orthop Relat Res. 1993;296:295.[PubMed]
  • 12. Park Y. Sugimoto M. Watrin A. Chiquet M. Hunziker E.B. BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel. Osteoarthritis Cartilage. 2005;13:527.[PubMed]
  • 13. Shirasawa S. Sekiya I. Sakaguchi Y. Yagishita K. Ichinose S. Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006;97:84.[PubMed]
  • 14. Nishimura K. Solchaga L.A. Caplan A.I. Yoo J.U. Goldberg V.M. Johnstone B. Chondroprogenitor cells of synovial tissue. Arthritis Rheum. 1999;42:2631.[PubMed]
  • 15. Mochizuki T. Muneta T. Sakaguchi Y. Nimura A. Yokoyama A. Koga H. Sekiya I. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum. 2006;54:843.[PubMed]
  • 16. Worster A.A. Brower-Toland B.D. Fortier L.A. Bent S.J. Williams J. Nixon A.J. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res. 2001;19:738.[PubMed]
  • 17. Longobardi L. O'Rear L. Aakula S. Johnstone B. Shimer K. Chytil A. Horton W.A. Moses H.L. Spagnoli A. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006;21:626.[PubMed]
  • 18. Majumdar M.K. Wang E. Morris E.A. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol. 2001;189:275.[PubMed]
  • 19. Edwards J.CThe nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation. J Anat. 1994;184(Pt 3):493.[Google Scholar]
  • 20. Vandenabeele F. De Bari C. Moreels M. Lambrichts I. Dell'Accio F. Lippens P.L. Luyten F.P. Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane. Arch Histol Cytol. 2003;66:145.[PubMed]
  • 21. Bonab M.M. Alimoghaddam K. Talebian F. Ghaffari S.H. Ghavamzadeh A. Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14.
  • 22. Crisostomo P.R. Wang M. Wairiuko G.M. Morrell E.D. Terrell A.M. Seshadri P. Nam U.H. Meldrum D.R. High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock. 2006;26:575.[PubMed]
  • 23. Allen K.D. Athanasiou K.A. Effect of passage and topography on gene expression of temporomandibular joint disc cells. Tissue Eng. 2007;13:101.[PubMed]
  • 24. Kang S.W. Yoo S.P. Kim B.S. Effect of chondrocyte passage number on histological aspects of tissue-engineered cartilage. Biomed Mater Eng. 2007;17:269.[PubMed]
  • 25. Zimmermann T. Kunisch E. Pfeiffer R. Hirth A. Stahl H.D. Sack U. Laube A. Liesaus E. Roth A. Palombo-Kinne E. Emmrich F. Kinne R.W. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture—primary culture cells markedly differ from fourth-passage cells. Arthritis Res. 2001;3:72.
  • 26. Johnstone B. Hering T.M. Caplan A.I. Goldberg V.M. Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265.[PubMed]
  • 27. Bilgen B. Orsini E. Aaron R.K. Ciombor D.M. FBS suppresses TGF-beta-1-induced chondrogenesis in synoviocyte pellet cultures while dexamethasone and dynamic stimuli are beneficial. J Tissue Eng Regen Med. 2007;1:436.[PubMed]
  • 28. Kim Y.-J. Sah R.L.Y. Doong J.-Y. Grodzinsky A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem. 1988;174:168.[PubMed]
  • 29. Farndale R.W. Buttle D.J. Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986;883:173.[PubMed]
  • 30. Livak K.J. Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402.[PubMed]
  • 31. Sakaguchi Y. Sekiya I. Yagishita K. Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005;52:2521.[PubMed]
  • 32. Rosengren S. Boyle D.L. Firestein G.S. Acquisition, culture, and phenotyping of synovial fibroblasts. Methods Mol Med. 2007;135:365.[PubMed]
  • 33. Kurth T. Hedbom E. Shintani N. Sugimoto M. Chen F.H. Haspl M. Martinovic S. Hunziker E.B. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthritis Cartilage. 2007;15:1178.[PubMed]
  • 34. Sakimura K. Matsumoto T. Miyamoto C. Osaki M. Shindo H. Effects of insulin-like growth factor I on transforming growth factor beta1 induced chondrogenesis of synovium-derived mesenchymal stem cells cultured in a polyglycolic acid scaffold. Cells Tissues Organs. 2006;183:55.[PubMed]
  • 35. Fortier L.A. Mohammed H.O. Lust G. Nixon A.J. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br. 2002;84:276.[PubMed]
  • 36. Chen J. Baer A.E. Paik P.Y. Yan W. Setton L.A. Matrix protein gene expression in intervertebral disc cells subjected to altered osmolarity. Biochem Biophys Res Commun. 2002;293:932.[PubMed]
  • 37. Upton M.L. Chen J. Setton L.A. Region-specific constitutive gene expression in the adult porcine meniscus. J Orthop Res. 2006;24:1562.[PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.